XML 12 R6.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE NONCONTROLLING INTERESTS AND SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Number of Series A Preferred Shares Outstanding
Total Shareholders' Equity Attributable to Bruker Corporation
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive (Loss) Income, Net of tax
Noncontrolling Interests in Consolidated Subsidiaries
Redeemable Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2023 $ 1,394.6   $ 1,377.2 $ 1.7 $ (1,237.2) $ 282.9 $ 2,323.8 $ 6.0 $ 17.4 $ 18.7
Balance (in shares) at Dec. 31, 2023       145,164,826            
Balance Treasury Shares at Dec. 31, 2023         30,778,879          
Increase (Decrease) in Stockholders' Equity                    
Stock options exercised 3.4   3.4     3.4        
Stock options exercised (in shares)       146,765            
Restricted Stock units vested (in shares)       23,051            
Stock based compensation 4.6   4.6     4.6        
Employee stock purchase plan 0.2   0.2     0.2        
Cash dividends paid to common shareholders (7.3)   (7.3)       (7.3)      
Loans to noncontrolling interest (0.9)               (0.9)  
Consolidated net income (loss) 52.3   50.9       50.9   1.4 (0.3)
Other comprehensive income (loss) (14.0)   (13.7)         (13.7) (0.3) (0.5)
Balance at end of period at Mar. 31, 2024 1,432.9   1,415.3 $ 1.7 $ (1,237.2) 291.1 2,367.4 (7.7) 17.6 17.9
Balance ending (in shares) at Mar. 31, 2024       145,334,642            
Balance Treasury Shares at Mar. 31, 2024         30,778,879          
Increase (Decrease) in Stockholders' Equity                    
Stock options exercised 0.5   0.5     0.5        
Stock options exercised (in shares)       24,484            
Restricted Stock units vested (0.1)   (0.1)     (0.1)        
Restricted Stock units vested (in shares)       1,404            
Stock based compensation 4.8   4.8     4.8        
Employee stock purchase plan 2.1   2.1     2.1        
Employee Stock Purchase Plan (in shares)       31,291            
Public Offering, net of issuance costs of $0.8 million 403.0   403.0 $ 0.1   402.9        
Public Offering, net of issuance costs of $0.8 million, shares       6,000,000            
Cash dividends paid to common shareholders (7.7)   (7.7)       (7.7)      
Consolidated net income (loss) 7.9   7.6       7.6   0.3 (0.3)
Other comprehensive income (loss) (36.4)   (36.3)         (36.3) (0.1) (0.1)
Balance at end of period at Jun. 30, 2024 1,807.0   1,789.2 $ 1.8 $ (1,237.2) 701.3 2,367.3 (44.0) 17.8 17.5
Balance ending (in shares) at Jun. 30, 2024       151,391,821            
Balance Treasury Shares at Jun. 30, 2024         30,778,879          
Increase (Decrease) in Stockholders' Equity                    
Stock options exercised 0.4   0.4     0.4        
Stock options exercised (in shares)       15,418            
Restricted Stock units vested (3.2)   (3.2)     (3.2)        
Restricted Stock units vested (in shares)       187,445            
Stock based compensation 5.2   5.2     5.2       0.1
Employee stock purchase plan 0.4   0.4     0.4        
Cash dividends paid to common shareholders (7.6)   (7.6)       (7.6)      
Consolidated net income (loss) 40.5   40.9       40.9   (0.4) (0.2)
Other comprehensive income (loss) (17.6)   (18.3)         (18.3) 0.7 0.6
Balance at end of period at Sep. 30, 2024 1,825.1   1,807.0 $ 1.8 $ (1,237.2) 704.1 2,400.6 (62.3) 18.1 18.0
Balance ending (in shares) at Sep. 30, 2024       151,594,684            
Balance Treasury Shares at Sep. 30, 2024         30,778,879          
Balance at beginning of period at Dec. 31, 2024 $ 1,797.1   1,781.2 $ 1.8 $ (1,237.2) 713.4 2,406.7 (103.5) 15.9 18.1
Balance (in shares) at Dec. 31, 2024       151,677,952            
Balance Treasury Shares at Dec. 31, 2024 30,778,879       30,778,879          
Increase (Decrease) in Stockholders' Equity                    
Stock options exercised $ 0.4   0.4     0.4        
Stock options exercised (in shares)       18,771            
Restricted Stock units vested (in shares)       24,999            
Stock based compensation 5.2   5.2     5.2        
Employee stock purchase plan 0.4   0.4     0.4        
Shares Repurchased (10.1)   (10.1)   $ (10.0) (0.1)        
Shares Repurchased (in shares)       (200,731) 200,731          
Cash dividends paid to common shareholders (7.7)   (7.7)       (7.7)      
Proceeds from the sale of (distributions to) noncontrolling interests, net (0.5)               (0.5)  
Consolidated net income (loss) 17.1   17.4       17.4   (0.3) (0.4)
Other comprehensive income (loss) 31.0   30.4         30.4 0.6 0.6
Balance at end of period at Mar. 31, 2025 1,832.9   1,817.2 $ 1.8 $ (1,247.2) 719.3 2,416.4 (73.1) 15.7 18.3
Balance ending (in shares) at Mar. 31, 2025       151,520,991            
Balance Treasury Shares at Mar. 31, 2025         30,979,610          
Increase (Decrease) in Stockholders' Equity                    
Stock options exercised 1.8   1.8     1.8        
Stock options exercised (in shares)       87,487            
Restricted Stock units vested (0.1)   (0.1)     (0.1)        
Restricted Stock units vested (in shares)       7,334            
Stock based compensation 5.3   5.3     5.3        
Employee stock purchase plan 3.7   3.7     3.7        
Employee Stock Purchase Plan (in shares)       100,115            
Cash dividends paid to common shareholders (7.6)   (7.6)       (7.6)      
Consolidated net income (loss) 6.0   7.6       7.6   (1.6) (1.7)
Certain other acquisitions                   28.3
Other comprehensive income (loss) (22.6)   (23.9)         (23.9) 1.3 2.5
Balance at end of period at Jun. 30, 2025 1,819.4   1,804.0 $ 1.8 $ (1,247.2) 730.0 2,416.4 (97.0) 15.4 47.4
Balance ending (in shares) at Jun. 30, 2025       151,715,927            
Balance Treasury Shares at Jun. 30, 2025         30,979,610          
Increase (Decrease) in Stockholders' Equity                    
Stock options exercised 0.4   0.4     0.4        
Stock options exercised (in shares)       20,086            
Restricted Stock units vested (1.6)   (1.6)     (1.6)        
Restricted Stock units vested (in shares)       204,673            
Stock based compensation 5.5   5.5     5.5        
Employee stock purchase plan 0.5   0.5     0.5        
Issuance of Series A Mandatory Convertible Preferred Stock, Shares   2,760,000                
Issuance of Series A Mandatory Convertible Preferred Stock, Value 669.5   669.5     669.5        
Dividends accrued on common shareholders (7.6)   (7.6)       (7.6)      
Dividends accrued on Series A Mandatory Convertible Preferred Stock, net of isuance costs (2.8)   (2.8)       (2.8)      
Consolidated net income (loss) (59.6)   (59.6)       (59.6)     1.1
Certain other acquisitions 8.0   5.8       5.8   2.2 (5.5)
Other comprehensive income (loss) 17.8   17.8         17.8   (0.1)
Balance at end of period at Sep. 30, 2025 $ 2,449.5   $ 2,431.9 $ 1.8 $ (1,247.2) $ 1,404.3 $ 2,352.2 $ (79.2) $ 17.6 $ 42.9
Balance ending (in shares) at Sep. 30, 2025   2,760,000   151,940,686            
Balance Treasury Shares at Sep. 30, 2025 30,979,610       30,979,610